Article
Effects of germline DHFR and FPGS variants on methotrexate metabolism and relapse of leukemia.
Blood - 3 Sept 2020
Tulstrup Morten, Moriyama Takaya, Jiang Chuang, Grosjean Marie, Nersting Jacob, Abrahamsson Jonas, Grell Kathrine, Hjalgrim Lisa Lyngsie, Jónsson Ólafur Gísli, Kanerva Jukka, Lund Bendik, Nielsen Stine Nygaard, Nielsen Rikke Linnemann, Overgaard Ulrik, Quist-Paulsen Petter, Pruunsild Kaie, Vaitkeviciene Goda, Wolthers Benjamin Ole, Zhang Hui, Gupta Ramneek, Yang Jun J, Schmiegelow Kjeld
Abstract excerpt
Methotrexate (MTX) during maintenance therapy is essential for curing acute lymphoblastic leukemia (ALL), but dosing strategies aiming at adequate treatment intensity are challenged by interindividual differences in drug disposition. To evaluate genetic factors associated with MTX metabolism, we performed a genome-wide association study in 447 ALL cases from the Nordic Society for Pediatric Haematology and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
